Request Download Report

View Synopsis & Table of Content
{reportSlug=global-t-cell-immunotherapy-market, reportId=53093, mktKeyword=T-Cell Immunotherapy, cagr=16.42, publishDate=Jan 2024, priceOption2=7500, reportTitle=T-Cell Immunotherapy Comprehensive Study by Type (Active Immunotherapy, Passive Immunotherapy), Application (Stomach Cancer, Lung Cancer, Colorectal Cancer, Esophagus Cancer, Pancreatic Cancer, Others), Modility (Research, Commercialized), Product Class (Monoclonal Antibodies, Oncolytic Virus Therapy, Bispecific Antibodies, Cytokines), Indication (Hematologic Malignancies (Lymphoma, Leukemia, Myeloma), Solid Tumors (Melanoma, Brain & Central Nervous System, Liver Cancer, Others)), Therapy Type (CAR T-cell Therapy, T Cell Receptor (TCR)-based, Tumor-Infiltrating Lymphocytes (TIL)-based), End User (Hospitals, Cancer Research Centers, Clinics) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=200, priceOption1=3750, forecastYr=2030, noOfPages=208, reportKey=52787, breadcrum=Global T-Cell Immunotherapy}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Jan 2024 208 Pages 55 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales